NASDAQ:TEM Tempus AI (TEM) Stock Price, News & Analysis $76.50 -5.40 (-6.59%) Closing price 10/1/2026 04:00 PM EasternExtended Trading$77.14 +0.64 (+0.84%) As of 04:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOwnershipSEC FilingsShort Interest About Tempus AI Stock (NASDAQ:TEM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Tempus AI alerts:Sign Up Key Stats Today's Range$75.92▼$82.8150-Day Range$41.55▼$85.0852-Week Range$40.77▼$104.32Volume7.16 million shsAverage Volume6.54 million shsMarket Capitalization$13.80 billionP/E RatioN/ADividend YieldN/APrice Target$71.05Consensus RatingHold Company Overview Tempus AI, Inc. is a technology company focused on applying artificial intelligence and data analytics to precision medicine. The company develops tools intended to help physicians make more informed treatment decisions by combining clinical information, molecular data and other health-related datasets. Tempus provides genomic testing and diagnostic services, including sequencing and other molecular tests used primarily in oncology. Its platform also offers data and software solutions designed to support clinical research, pharmaceutical development, patient identification for clinical trials and the development of personalized treatment strategies. Founded in 2015, Tempus is headquartered in Chicago and primarily serves healthcare providers, researchers and life sciences companies. The company was co-founded by Eric Lefkofsky, who serves as its chief executive officer.AI Generated. May Contain Errors. Read More Tempus AI Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks33rd Percentile Overall ScoreTEM MarketRank™: Tempus AI scored higher than 33% of companies evaluated by MarketBeat, and ranked 739th out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.2 / 5Analyst RatingHold Consensus RatingTempus AI has received a consensus rating of Hold. The company's average rating score is 2.41, and is based on no strong buy ratings, 11 buy ratings, 9 hold ratings, and 2 sell ratings.Downside RiskTempus AI has a consensus price target of $71.05, representing about 7.1% downside from its current price of $76.50.Amount of Analyst CoverageTempus AI has been the subject of 14 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Tempus AI's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Tempus AI are expected to grow in the coming year, from ($1.38) to ($1.00) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Tempus AI is -53.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Tempus AI is -53.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTempus AI has a P/B Ratio of 27.72. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Tempus AI's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted20.53% of the float of Tempus AI has been sold short.Short Interest Ratio / Days to CoverTempus AI has a short interest ratio ("days to cover") of 5.16.Change versus previous monthShort interest in Tempus AI has recently decreased by 4.77%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldTempus AI does not currently pay a dividend.Dividend GrowthTempus AI does not have a long track record of dividend growth. News and Social Media3.0 / 5News Sentiment0.76 News SentimentTempus AI has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 14 news articles for Tempus AI this week, compared to 10 articles on an average week.Search InterestOnly 50 people have searched for TEM on MarketBeat in the last 30 days. This is a decrease of -21% compared to the previous 30 days.MarketBeat Follows30 people have added Tempus AI to their MarketBeat watchlist in the last 30 days. This is an increase of 131% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Tempus AI insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $82,907,732.00 in company stock.Percentage Held by Insiders24.26% of the stock of Tempus AI is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions24.22% of the stock of Tempus AI is held by institutions.Read more about Tempus AI's insider trading history. Receive TEM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tempus AI and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TEM Stock News HeadlinesTempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026October 1 at 8:34 AM | businesswire.comTop Artificial Intelligence Stocks To Consider - September 28thSeptember 30 at 1:01 AM | americanbankingnews.comA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the eye-popping yields are fueling a boom among everyday investors. Three years ago, barely a dozen of these funds existed - today there are more than 100, holding over $140 billion. These funds trade on the NYSE and NASDAQ and are built to generate monthly income. Some investors are targeting $5,000 a month with roughly one-tenth of the nest egg Wall Street says you need. | Investors Alley (Ad)Best Artificial Intelligence Stocks Worth Watching - September 27thSeptember 29 at 1:01 AM | americanbankingnews.comTempus AI, Inc. Receives FDA Clearance For Tempus ECG-MR AI Product Designed To Identify Undiagnosed Mitral RegurgitationSeptember 28, 2026 | marketscreener.comMInsider Selling: Tempus AI (NASDAQ:TEM) CEO Sells 250,000 Shares of Company StockSeptember 25, 2026 | insidertrades.comInsider Selling: Tempus AI (NASDAQ:TEM) CEO Sells $49,000.00 in StockSeptember 19, 2026 | insidertrades.comTempus AI (NASDAQ:TEM) Director Nadja West Sells 3,000 SharesSeptember 2, 2026 | insidertrades.comSee More Headlines TEM Stock Analysis - Frequently Asked Questions How have TEM shares performed this year? Tempus AI's stock was trading at $59.05 on January 1st, 2026. Since then, TEM stock has increased by 29.6% and is now trading at $76.50. How were Tempus AI's earnings last quarter? Tempus AI, Inc. (NASDAQ:TEM) announced its earnings results on Thursday, July, 30th. The company reported ($0.04) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.14) by $0.10. The business's quarterly revenue was up 21.6% compared to the same quarter last year. Read the conference call transcript. When did Tempus AI IPO? Tempus AI (TEM) raised $400 million in an initial public offering on Wednesday, June 12th 2024. The company issued 11,100,000 shares at a price of $35.00-$37.00 per share. How do I buy shares of Tempus AI? Shares of TEM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Tempus AI own? Based on aggregate information from My MarketBeat watchlists, some other companies that Tempus AI investors own include AST SpaceMobile (ASTS), NVIDIA (NVDA), Broadcom (AVGO), Micron Technology (MU), Recursion Pharmaceuticals (RXRX), Genius Sports (GENI) and Super Micro Computer (SMCI). Company Calendar Last Earnings7/30/2026Today10/01/2026Next Earnings (Estimated)11/03/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 TEM's financial health is in the Green zone, according to TradeSmith. TEM has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNASDAQ:TEM Previous SymbolNASDAQ:TEM CIK1717115 Webwww.tempus.com Phone800-976-5448FaxN/AEmployees3,800Year Founded2015Price Target and Rating Average Price Target for Tempus AI$71.05 High Price Target$100.00 Low Price Target$35.00 Potential Upside/Downside-7.1%Consensus RatingHold Rating Score (0-4)2.41 Research Coverage22 Analysts Profitability EPS (Trailing Twelve Months)($1.44) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$245.03 million Net Margins-17.77% Pretax Margin-17.62% Return on Equity-50.28% Return on Assets-10.33% Debt Debt-to-Equity Ratio3.06 Current Ratio3.30 Quick Ratio3.16 Sales & Book Value Annual Sales$1.27 billion Price / Sales10.85 Cash FlowN/A Price / Cash FlowN/A Book Value$2.76 per share Price / Book27.72Miscellaneous Outstanding Shares180,430,000Free Float136,661,000Market Cap$13.80 billion OptionableN/A Beta3.53 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NASDAQ:TEM) was last updated on 10/2/2026 by MarketBeat.com Staff. From Our PartnersThey're not telling you how bad this could getValuations are stretched to levels seen only a handful of times in the past century, while a growing debt spir...Parkview Capital Group | SponsoredA major gold reset could be closer than people thinkFor 50 years, Washington has held 8,133 tonnes of gold on its books at a fraction of today's market price. One...Reagan Gold Group | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredUrgent Attention to Executive Order #14363 (Buy This Stock Before Oct. 20thMarc Chaikin, a 60-year Wall Street veteran whose past clients include George Soros and Steve Cohen, built a s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tempus AI, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tempus AI With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
